PACYLEX PHARMACEUTICALS INC.

Profile

Company Names

PACYLEX PHARMACEUTICALS INC.

Addresses

400 3RD AVENUE SW, SUITE 3700, CALGARY, A0 T2P 4H2

10230 JASPER AVENUE, SUITE 4000, EDMONTON, A0 T5J 4P6

Phone Numbers

780-264-4295

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$7,259,198.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-03-21 
$75,000.00 
$75,000.00 
$0.00 
Equity 
1
2021-05-28 
$7,184,198.00 
$7,184,198.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LUC 
G. 
BERTHIAUME 
DIRECTOR
PACYLEX PHARMACEUTICALS INC.
AJIT 
 
GILL 
DIRECTOR
ON DEMAND THERAPEUTICS, INC.   |  PACYLEX PHARMACEUTICALS INC.
RYAN 
 
HEIT 
EXECUTIVE OFFICER
PACYLEX PHARMACEUTICALS INC.
MARK 
 
HUSON 
DIRECTOR
PACYLEX PHARMACEUTICALS INC.
CINDY 
 
JACOBS 
DIRECTOR
ONCOGENEX PHARMACEUTICALS, INC.   |  PACYLEX PHARMACEUTICALS INC.   |  ACHIEVE LIFE SCIENCES, INC.
JOHN 
 
MACKEY 
DIRECTOR
PACYLEX PHARMACEUTICALS INC.   |  HEALTHY AMERICA, LLC   |  ILLUMISONICS INC.
NOLA 
 
MASTERSON 
DIRECTOR
REPROS THERAPEUTICS INC.   |  RESONANCE MEDICAL LLC   |  ZIVO BIOSCIENCE, INC.   |  PACYLEX PHARMACEUTICALS INC.
MICHAEL 
 
WEICKERT 
EXECUTIVE OFFICER, DIRECTOR
PACYLEX PHARMACEUTICALS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-21 
2021-06-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#